Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Houston, Texas 77030


Purpose:

The purpose of this study is to determine how many patients with Parkinson's disease have compulsive behaviors, and what types of behaviors they have. This study will also determine if acamprosate can be used to treat compulsive behaviors in Parkinson's disease patients.


Criteria:

Inclusion Criteria: 1. Idiopathic Parkinson's disease 2. Active dopaminergic therapy at stable dose for one month (levodopa or dopamine agonist) 3. Able and willing to complete Rating Scales 4. Presence of one or more compulsive behavior based on responses to Rating Scales (defined as >5 on the SOGS; >17 on the YBOCS-SV and YBOCS-CUV; >1.7 on the SCS for women and >2.1 on the SCS for men; >15 on the YBOCS-BE, >5.5 on the CQ). 5. Written informed consent Inclusion criteria (controls): 1. No significant psychiatric disease 2. Able and willing to complete Rating Scales 3. Written informed consent Exclusion Criteria: 1. No anticipated need for adjustment of medications for Parkinson's disease 2. Current participation in another clinical study 3. History of unstable psychiatric disease (as determined by the Principal Investigator) 4. Women of childbearing age not using appropriate contraceptive methods (oral contraceptives, condoms, surgery)


NCT ID:

NCT00640952


Primary Contact:

Principal Investigator
Joohi Jimenez-Shahed, MD
Baylor College of Medicine


Backup Contact:

N/A


Location Contact:

Houston, Texas 77030
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.